secwatch.observer — SEC 8-K summary
======================================

Issuer:     SenesTech, Inc. (SNES)
CIK:        0001680378
Form:       8-K
Filed at:   2024-08-05T23:59:59+00:00
Accession:  0001628280-24-034717
Event type: regulatory
Sentiment:  negative
Materiality: 0.55
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

SenesTech receives Nasdaq non-compliance notice for audit committee independence; cure period granted
--------------------------------------------------------------------------------

- Director Delphine François Chiavarini left board and audit committee at 2024 annual meeting, leaving audit committee below three independent members.
- Nasdaq granted cure period until earlier of next annual meeting or July 11, 2025; if annual meeting before Jan 7, 2025, compliance due by Jan 7, 2025.
- Company intends to identify and appoint a new independent director to regain compliance during cure period.
- No immediate effect on common stock listing on Nasdaq Capital Market, but compliance cannot be assured.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1680378/000162828024034717/0001628280-24-034717-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1680378/000162828024034717/snes-20240731.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-034717

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer